These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

84 related articles for article (PubMed ID: 2434015)

  • 1. Surgical procedures for ovarian cancer.
    Shepherd JH; Crowther ME; Ward BG; Singh P
    Ann R Coll Surg Engl; 1986 Nov; 68(6):315-8. PubMed ID: 2434015
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The benefits of comprehensive surgical staging in the management of early-stage epithelial ovarian carcinoma.
    Le T; Adolph A; Krepart GV; Lotocki R; Heywood MS
    Gynecol Oncol; 2002 May; 85(2):351-5. PubMed ID: 11972399
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Platin-based chemotherapy and salvage surgery in recurrent ovarian cancer following negative second-look laparotomy.
    Landoni F; Pellegrino A; Cormio G; Milani R; Maggioni A; Mangioni C
    Acta Obstet Gynecol Scand; 1998 Feb; 77(2):233-7. PubMed ID: 9512334
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Second-look laparotomy in ovarian cancer.
    Creasman WT
    Gynecol Oncol; 1994 Dec; 55(3 Pt 2):S122-7. PubMed ID: 7835795
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neoadjuvant chemotherapy for unresectable ovarian carcinoma: a French multicenter study.
    Ansquer Y; Leblanc E; Clough K; Morice P; Dauplat J; Mathevet P; Lhommé C; Scherer C; Tigaud JD; Benchaib M; Fourme E; Castaigne D; Querleu D; Dargent D
    Cancer; 2001 Jun; 91(12):2329-34. PubMed ID: 11413522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Current surgical management in ovarian cancer recurrences].
    Tinelli FG; Tinelli A; Campagnutta E; Kobal B; Rakar S; Manca C; Tinelli R; Perrone A
    Minerva Ginecol; 2004 Oct; 56(5):457-67. PubMed ID: 15531862
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Is there a role for second-look laparotomy in the management of malignant germ cell tumors of the ovary? Experience at Institut Gustave Roussy.
    Culine S; Lhomme C; Michel G; Leclere J; Duvillard P; Droz JP
    J Surg Oncol; 1996 May; 62(1):40-5. PubMed ID: 8618400
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Multidisciplinary management of the elderly patient with ovarian cancer.
    Capen CV; Baker DP
    Clin Geriatr Med; 1985 May; 1(2):345-58. PubMed ID: 3830369
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Indicators of survival duration in ovarian cancer and implications for aggressiveness of care.
    von Gruenigen V; Daly B; Gibbons H; Hutchins J; Green A
    Cancer; 2008 May; 112(10):2221-7. PubMed ID: 18348300
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Surgical cytoreduction during second-look laparotomy in patients with advanced ovarian cancer.
    Gadducci A; Iacconi P; Fanucchi A; Cosio S; Teti G; Genazzani AR
    Anticancer Res; 2000; 20(3B):1959-64. PubMed ID: 10928134
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of secondary cytoreductive surgery on survival of patients with advanced epithelial ovarian cancer.
    Zang RY; Zhang ZY; Li ZT; Cai SM; Tang MQ; Chen J; Liu Q
    Eur J Surg Oncol; 2000 Dec; 26(8):798-804. PubMed ID: 11087649
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of surgery in ovarian carcinoma.
    Fader AN; Rose PG
    J Clin Oncol; 2007 Jul; 25(20):2873-83. PubMed ID: 17617518
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytoreductive surgery in ovarian carcinoma patients with a documented previously complete surgical response.
    Vaccarello L; Rubin SC; Vlamis V; Wong G; Jones WB; Lewis JL; Hoskins WJ
    Gynecol Oncol; 1995 Apr; 57(1):61-5. PubMed ID: 7705701
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neoadjuvant (cytoreductive) chemotherapy combined with intervention debulking surgery in advanced, unresected epithelial ovarian cancer.
    Lawton FG; Redman CW; Luesley DM; Chan KK; Blackledge G
    Obstet Gynecol; 1989 Jan; 73(1):61-5. PubMed ID: 2462202
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reoperation for palliation of recurrent malignant bowel obstruction in ovarian carcinoma.
    Pothuri B; Meyer L; Gerardi M; Barakat RR; Chi DS
    Gynecol Oncol; 2004 Oct; 95(1):193-5. PubMed ID: 15385131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of surgeon specialty on processes of care and outcomes for ovarian cancer patients.
    Earle CC; Schrag D; Neville BA; Yabroff KR; Topor M; Fahey A; Trimble EL; Bodurka DC; Bristow RE; Carney M; Warren JL
    J Natl Cancer Inst; 2006 Feb; 98(3):172-80. PubMed ID: 16449677
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Ovarian cancer in the octogenarian: does the paradigm of aggressive cytoreductive surgery and chemotherapy still apply?
    Moore KN; Reid MS; Fong DN; Myers TK; Landrum LM; Moxley KM; Walker JL; McMeekin DS; Mannel RS
    Gynecol Oncol; 2008 Aug; 110(2):133-9. PubMed ID: 18495221
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Second surgery in the management of ovarian cancer].
    Scarabelli C; Campagnutta E; Zarrelli A; De Piero G; Sopracordevole F; Visentin MC; Giorda G; Sasso GM; Parin A; Gallo A
    Minerva Ginecol; 1994; 46(1-2):5-13. PubMed ID: 8177464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Experience in first-line chemotherapy with paclitaxel for the treatment of ovarian carcinomas].
    Pete I; Szánthó A; Mayer A; Thurzó L; Pulay T
    Orv Hetil; 2003 May; 144(19):919-24. PubMed ID: 12809068
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Medical therapy of advanced malignant epithelial tumours of the ovary.
    Colombo N; Parma G; Bocciolone L; Franchi D; Sideri M; Maggioni A
    Forum (Genova); 2000; 10(4):323-32. PubMed ID: 11535983
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.